Novartis acquires Arctos Medical to expand optogenetics portfolio

Novartis acquires Arctos Medical to expand optogenetics portfolio

Source: 
Biopharma Reporter
snippet: 

Novartis has acquired Arctos Medical, a Swiss gene therapy start-up developing optogenetic therapies for treating blindness.